How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis?

Abstract

Abstract Sepsis results in complex alterations to the immune system. Our understanding of how these alterations in immune responses could help characterize extreme immune phenotypes, identify biomarkers with the ability to stratify patients for therapeutic interventions, surrogates in the causal pathway of clinical end-points, and treatable traits are still rudimentary. A methodologically rigorous, consensus-based approach should enrich sepsis immune subpopulations to increase the probability of successful trials.

Keywords

• Sepsis
• Immunology
• Trials
• Host response